Nephrotic Syndrome Caused by Membranous Nephropathy : Response to a Short Course of Cyclophosphamide Alternating with Prednisolone
スポンサーリンク
概要
- 論文の詳細を見る
Objective The optimal duration of immunosuppressive therapy and the timing of treatment for treating membranous nephropathy (MN) have yet to be established. We examined outcomes of a short course of cyclophosphamide alternating with prednisolone for MN patients with nephrotic syndrome. Methods and Patients Cyclophosphamide (2 mg/kg/day for 8 weeks) combined with prednisolone (1 mg/kg every 48 hours for 8 weeks, then tapering off for 1 year) was prescribed for 28 MN patients (12 men and 16 women; mean age 52.4±2.25 years SEM). We first evaluated the response rates to this combined therapy, then compared the clinical characteristics of those who achieved remission (group A) with those who did not (group B) within 6 months of the start of treatment. Results The incidences of complete and partial remission increased with the follow-up period; 32 and 21% by 6 months, 54 and 29% by 12 months, and 79 and 11% by 24 months, respectively. Serum IgG (906±100.8 versus 562±66.1 mg/day; p<0.01) was significantly higher in group A, and the selectivity index (CIgG/Calbumin 0.16±0.015 versus 0.30±0.040; p<0.01), significantly lower. Nephrotic syndrome persisted in 3 group B patients (23%), who finally had impaired renal function. Conclusion MN patients with nephrotic syndrome responded favorably to a short course of cyclophosphamide combined with prednisolone. The serum IgG level and selectivity index may serve as markers of early response to this treatment.
- 社団法人 日本内科学会の論文
- 2004-01-01
著者
-
Eto Tanenao
Etoh Clinic
-
Eto T
Circulatory And Body Fluid Regulation Faculty Of Medicine University Of Miyazaki
-
Fujimoto Shinichi
奈良県立医科大学 総合医療学
-
Eto Tanenao
First Department Of Internal Medicine Faculty Of Medicine University Of Miyazaki
-
Eto T
First Department Of Internal Medicine Miyazaki Medical College University Of Miyazaki
-
Eto Tanenao
宮崎大学 循環体液制御学
-
FUJIMOTO Shouichi
First Department of Internal Medicine, Miyazaki Medical College, University of Miyazaki
-
SATO Yuji
First Department of Internal Medicine, Miyazaki Medical College, University of Miyazaki
-
YAMADA Kazuhiro
First Department of Internal Medicine, Miyazaki Medical College, University of Miyazaki
-
HARA Seiichirou
First Department of Internal Medicine, Miyazaki Medical College, University of Miyazaki
-
HISANAGA Shuichi
First Department of Internal Medicine, Miyazaki Medical College, University of Miyazaki
-
Yamada Kazuhiro
First Department Of Internal Medicine Miyazaki Medical College University Of Miyazaki
-
Hara Seiichiro
First Department Of Internal Medicine Miyazaki Medical College University Of Miyazaki
-
Eto Tanenao
First Department Of Internal Medicine Department Of Pathology Miyazaki Medical College
-
Hisanaga Shuichi
宮崎医科大学 1内
-
Sato Yuji
First Department Of Internal Medicine Miyazaki Medical College University Of Miyazaki
-
Hisanaga Shuichi
The First Department Of Internal Medicine Miyazaki Medical College
-
Hisanaga Shuichi
First Department Of Internal Medicine Miyazaki Medical College University Of Miyazaki
関連論文
- One-year effectiveness and safety of open-label losartan/hydrochlorothiazide combination therapy in Japanese patients with hypertension uncontrolled with ARBs or ACE inhibitors
- The Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension
- OE-377 Papillary Muscle Gadolinium Late Enhancement : Frequency and Relationship with Mitral Regurgitation(MRI/MRA(01)(I),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- Protein-losing gastropathy associated with autoimmune disease : successful treatment with prednisolone
- OJ-047 Proangiotensin-12 : a New Member of Peptide for the Renin-angiotensin (RA) System(Hypertension, basic-2, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-487 Plasma Level of C-reactive Protein and Interleukin-6 are Related to Coronary Plaque Composition in Vivo(Atherosclerosis, clinical-12 (H) PJ82,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Socie
- PJ-344 Beneficial Effect of Soluble Guanylate Cyclase Stimulator BAY41-2272 on Cardiac Hypertrophy in Angiotensin II-induced Hypertensive Rats(Cardiovascular pharmacology, basic/clinical-4 (H) PJ58,Poster Session (Japanese),The 70th Anniversary Annual Sci
- PJ-308 Interleukin-10 in Coronary Plaques Obtained by Directional Atherectomy from Patients with Stable and Unstable Angina Pectoris(Angina pectoris, basic/clinical-4 (IHD) PJ52,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of t
- PJ-069 Stimulation of Soluble Guanylate Cyclase Abrogates Fibrosis in Hypertensive Rat Heart Induced by Angiotensin II(Hypertension, basic-4 (H) PJ12,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Soci
- OJ-263 High Molecular Weight Adiponectin in Coronary Circulation Increased in Patients without Coronary Artery Disease, But Not with Coronary Artery Disease(Coronary circulation, basic/clinical-2 (IHD) OJ44,Oral Presentation (Japanese),The 70th Anniversar